Viral proteins and Src family kinases: Mechanisms of pathogenicity from a "liaison dangereuse"
Mario Angelo Pagano1, Elena Tibaldi, Giorgio Palù
1Mario Angelo Pagano, Elena Tibaldi, Giorgio Palù, Anna Maria Brunati, Department of Molecular Medicine, University of Padua, Padua 35121, Italy.
Abstract:
To complete their life cycle and spread, viruses interfere with and gain control of diverse cellular processes, this most often occurring through interaction between viral proteins (VPs) and resident protein partners. Among the latter, Src family kinases (SFKs), a class of non-receptor tyrosine kinases that contributes to the conversion of extracellular signals into intracellular signaling cascades and is involved in virtually all cellular processes, have recently emerged as critical mediators between the cell's infrastructure and the viral demands. In this scenario, structural or ex novo synthesized VPs are able to bind to the different domains of these enzymes through specific short linear motifs present along their sequences. Proline-rich motifs displaying the conserved minimal consensus PxxP and recognizing the SFK Src homology (SH)3 domain constitute a cardinal signature for the formation of multiprotein complexes and this interaction may promote phosphorylation of VPs by SFKs, thus creating phosphotyrosine motifs that become a docking site for the SH2 domains of SFKs or other SH2 domain-bearing signaling molecules. Importantly, the formation of these assemblies also results in a change in the activity and/or location of SFKs, and these events are critical in perturbing key signaling pathways so that viruses can utilize the cell's machinery to their own benefit. In the light of these observations, although VPs as such, especially those with enzyme activity, are still regarded as valuable targets for therapeutic strategies, multiprotein complexes composed of viral and host cell proteins are increasingly becoming objects of investigation with a view to deeply characterize the structural aspects that favor their formation and to develop new compounds able to contrast viral diseases in an alternative manner.
Insights
Viruses hijack cellular processes by interacting with Src family kinases (SFKs) using viral proteins (VPs). Targeting these viral-host protein complexes offers a novel strategy against viral diseases.
Area of Science:
- Virology
- Molecular Cell Biology
- Biochemistry
Background:
- Viruses manipulate host cell machinery for replication and spread, often via viral protein (VP) interactions.
- Src family kinases (SFKs) are crucial signaling mediators involved in numerous cellular processes, increasingly recognized as key players in viral infections.
Purpose of the Study:
- To investigate the role of SFKs as mediators between cellular infrastructure and viral demands.
- To explore the formation and significance of multiprotein complexes between VPs and host cell proteins, specifically SFKs.
Main Methods:
- Analysis of short linear motifs (e.g., PxxP) in VPs that bind to SFK domains (e.g., SH3).
- Investigating the consequences of VP-SFK complex formation on SFK activity, localization, and downstream signaling.
- Examining the creation of phosphotyrosine motifs for subsequent signaling molecule recruitment (e.g., SH2 domains).
Main Results:
- Viral proteins bind to SFKs via specific motifs, forming multiprotein complexes.
- These interactions alter SFK activity and localization, perturbing cellular signaling pathways.
- VP phosphorylation by SFKs creates docking sites for other signaling proteins, further manipulating host cell functions.
Conclusions:
- VP-SFK interactions are critical for viruses to exploit host cell machinery.
- Multiprotein complexes of viral and host proteins are emerging targets for therapeutic strategies.
- Understanding these structural interactions may lead to novel antiviral compounds.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Retroviruses
Viral Recombination


